Decision

, 2006 FC 1493 (Perindopril*)

Justice Snider - 2007-01-03

Read full decision. Automatically generated summary:

The Plaintiffs (collectively referred to as Servier or the Plaintiffs) have brought a motion for an interlocutory injunction against the Defendants (collectively Apotex or the Defendants) to restrain them from using, making, selling, distributing, exporting, supplying and in any other way dealing with the compound perindopril and any pharmaceutically acceptable salts thereof, in the United Kingdom, Canada and Australia, on the basis that these activities allegedly infringe Canadian patent no. 1,341, 196 (the 196 Patent). The Plaintiffs sell the compound under the registered trademark name of COVERSYL. By Order dated November 29, 2006 (2006 FC 1443), Justice Simon Noël granted the Plaintiffs an interim injunction in relation to perindopril products destined for the Australian market.

Decision relates to:

  • T-1548-06 - LES LABORATOIRES SERVIER ET AL v. APOTEX INC. ET AL

 

Canadian Intellectual Property